{"disease":{"id":"scleroderma-localized","name":"scleroderma localized"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07292961","title":"Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma","phase":"NA","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT03740724","title":"A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Castle Creek Biosciences, LLC.","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}